BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10551898)

  • 21. Inhibitors of the complement system currently in development for cardiovascular disease.
    Pugsley MK; Abramova M; Cole T; Yang X; Ammons WS
    Cardiovasc Toxicol; 2003; 3(1):43-70. PubMed ID: 12668890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological manipulation of the complement system in human diseases.
    Asghar SS
    Front Biosci; 1996 Mar; 1():e15-25. PubMed ID: 9159241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract.
    Varsano S; Frolkis I; Ophir D
    Am J Respir Crit Care Med; 1995 Sep; 152(3):1087-93. PubMed ID: 7545058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The reactivity of the complement system.
    Hadding U
    Monogr Allergy; 1977; 12():36-45. PubMed ID: 335218
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic inhibition of the early phase of complement activation.
    Roos A; Ramwadhdoebé TH; Nauta AJ; Hack CE; Daha MR
    Immunobiology; 2002 Sep; 205(4-5):595-609. PubMed ID: 12396018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcal complement inhibitors: biological functions, recognition of complement components, and potential therapeutic implications.
    Geisbrecht BV
    Adv Exp Med Biol; 2008; 632():221-36. PubMed ID: 19025125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The complement system: an old story or target of new therapeutic approaches?].
    Heller A; Koch T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Apr; 35(4):207-13. PubMed ID: 10830072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Complement regulatory factors and immunologic recognition mechanism between species].
    Seya T; Matsunoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):637-42. PubMed ID: 8963770
    [No Abstract]   [Full Text] [Related]  

  • 29. Membrane-targeted complement inhibitors.
    Smith GP; Smith RA
    Mol Immunol; 2001 Aug; 38(2-3):249-55. PubMed ID: 11532286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The complement system and its biological activities].
    Colomb MG; Arlaud GJ
    C R Seances Soc Biol Fil; 1980; 174(4):615-26. PubMed ID: 6449243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement activation following oxidative stress.
    Collard CD; Lekowski R; Jordan JE; Agah A; Stahl GL
    Mol Immunol; 1999; 36(13-14):941-8. PubMed ID: 10698348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The regulation of complement activity by pharmacologic agents.
    Reynard AM
    J Immunopharmacol; 1980; 2(1):1-47. PubMed ID: 6256451
    [No Abstract]   [Full Text] [Related]  

  • 33. [Membrane-attacking complexes and membrane complement inhibitors on the leukocyte surface during combined exposure with meningococcus lipopolysaccharide and complement].
    Platonov AE; Vershinina IV; Serebrovskaia LV; Shepeleva GK
    Biull Eksp Biol Med; 1999 Apr; 127(4):433-8. PubMed ID: 10367130
    [No Abstract]   [Full Text] [Related]  

  • 34. The relevance of complement to virus biology.
    Blue CE; Spiller OB; Blackbourn DJ
    Virology; 2004 Feb; 319(2):176-84. PubMed ID: 15015499
    [No Abstract]   [Full Text] [Related]  

  • 35. Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches.
    Hajishengallis G; Maekawa T; Abe T; Hajishengallis E; Lambris JD
    Adv Exp Med Biol; 2015; 865():57-74. PubMed ID: 26306443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings.
    Keshavjee S; Davis RD; Zamora MR; de Perrot M; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):423-8. PubMed ID: 15678055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics.
    Sahu A; Lambris JD
    Immunopharmacology; 2000 Aug; 49(1-2):133-48. PubMed ID: 10904113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactions and side reactions to drugs.
    Rother U
    Prog Allergy; 1986; 39():123-33. PubMed ID: 3562461
    [No Abstract]   [Full Text] [Related]  

  • 39. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
    Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
    Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection.
    D'Ambrosio AL; Pinsky DJ; Connolly ES
    Mol Med; 2001 Jun; 7(6):367-82. PubMed ID: 11474130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.